Clinical Trials Logo

Filter by:
NCT ID: NCT04358744 Recruiting - Clinical trials for Autism Spectrum Disorder

The Real World Study of Autism Spectrum Disorder in China

Start date: April 13, 2019
Phase:
Study type: Observational [Patient Registry]

The investigators conduct the real world study to explore mechanisms of autism based on multi-modal data.

NCT ID: NCT04023591 Recruiting - Clinical trials for Spinal Cord Injuries

Nerve Transfer After Spinal Cord Injury- Multi-center

Start date: April 13, 2020
Phase:
Study type: Observational

Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of like and long-term functional independence will provide a significant public health impact. Specific aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and quality of life and functional independence.

NCT ID: NCT04042337 Recruiting - Clinical trials for Autism Spectrum Disorder

Improving Access to Pivotal Response Treatment (PRT) Via Telehealth Parent Training

Start date: April 13, 2020
Phase: N/A
Study type: Interventional

There is an urgent need for improved access to effective autism treatments. With advances in technology, distance learning models have particular promise for families who cannot access evidence-based parent training locally or may be on long wait-lists for behavioral treatments. Pivotal Response Treatment (PRT) is an established treatment for autism spectrum disorder (ASD); however, a telehealth PRT model has not yet been evaluated in a controlled trial. This study will examine the effects of training parents in PRT via secure video conferencing and investigate 1) whether parents can learn via telehealth to deliver PRT in the home setting (PRT-T) and 2) whether their children will show greater improvement in functional communication skills compared to children in a waitlist control group. Participants will include 40 children age 2 to 5 years with ASD and significant language delay. Eligible children will be randomly assigned to either PRT-T (N=20) or waiting list (N=20). Weekly 60-minute parent training sessions will be delivered for 12 weeks via secure video conferencing software by a PRT-trained study therapist. The effects of PRT-T on parent fidelity of PRT implementation, child communication deficits including frequency of functional verbal utterances, and parent-report of communication skills on standardized questionnaires will be evaluated. This research will provide a foundation for wider dissemination of technology-based solutions to improve access to ASD treatment.

NCT ID: NCT04191889 Recruiting - Clinical trials for C-staged Hepatocellular Carcinoma in BCLC Classification

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

TRIPLET
Start date: April 13, 2020
Phase: Phase 2
Study type: Interventional

This study was designed to evaluate the effectiveness and safety of hepatic arterial infusion chemotherapy combined with Apatinib and Camrelizumab (Triplet-combined Therapy) for C-staged Hepatocellular Carcinoma in BCLC classification. The primary outcome measure is to evaluate the objective response rate (ORR) of Triplet-combined Therapy for C-staged Hepatocellular Carcinoma in BCLC classification. The secondary Outcome measures include the duration of response (DOR), disease control rate (DCR), progression-free survival rate (PFSR) [ Time Frame: 6- and 12-month], overall survival rate (OSR) [ Time Frame: 6- and 12-month], the median progression-free survival time (mPFS) and median overall survival time (mOS) of Triplet-combined Therapy for C-staged Hepatocellular Carcinoma in BCLC classification. Moreover, this study aims to assess the safety and tolerability of Triplet-combined Therapy for C-staged Hepatocellular Carcinoma in BCLC classification.

NCT ID: NCT04324242 Recruiting - Low Back Pain Clinical Trials

Activating Transversus Abdominis Muscle

Start date: April 13, 2020
Phase:
Study type: Observational

Transversus abdominis (TrA) is an important muscle for spinal stabilization. Abdominal draw-in maneuver (ADIM) is a method that selectively activates TrA without activating external oblique (EO) and internal oblique (IO) muscles. Individuals with low back pain may have some troubles to understand proper contraction of TrA. Therefore, to contract the TrA, two different feedback techniques have been used to instruct. In this observational study we aim to investigate the effects of two different biofeedback methods to teach patients the proper activation of TrA muscle using ADIM. We aim to find out the differences between visual and traditional tactile biofeedback and decide which one is practical and easy to teach the patients in clinical environment.

NCT ID: NCT04331886 Recruiting - COVID-19 Clinical Trials

An Observational Study of Patients With Coronavirus Disease 2019

COVID-19
Start date: April 13, 2020
Phase:
Study type: Observational

This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.

NCT ID: NCT04352010 Recruiting - Mental Disorders Clinical Trials

Therapy Online Plus (TOP+) - Comparing Two Online Interventions for Dealing With Challenging Life Circumstances

TOP+
Start date: April 13, 2020
Phase: N/A
Study type: Interventional

Psychotherapy interventions can roughly be grouped into compensation-oriented strategies (compensating for and and modifying personal deficits of patients) versus capitalization-oriented strategies (building on patients' personal strengths). Improvement of emotion regulation (compensation-oriented) as well as the activation of resilience (capitalisation-oriented) have been identified as important transdiagnostic factors in the treatment of mental disorders. The study aims to compare compensation vs. capitalization strategies by using two online programs, centered either on emotion-regulation ("REMOTION") or on activating resilience ("Res-Up!"). Res-Up! and REMOTION are administered as stand-alone intervention or as add-on treatment to standard psychotherapy. Participants will be randomly assigned to three study conditions (Res-Up!, REMOTION, waiting control group). Outcomes are assessed at baseline, after six weeks and after twelve weeks.

NCT ID: NCT04357106 Recruiting - COVID-19 Clinical Trials

COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma

COPLA
Start date: April 13, 2020
Phase: Phase 2
Study type: Interventional

COVID-19 disease has become a very serious global health problem. Treatments for severe forms are urgently needed to lower mortality. Any procedure that improves these forms should be considered, especially those devoid of serious side effects.There is not enough published information on the use of allogeneic convalescent plasma (ACP) in the treatment of severe forms of COVID-19. The use of ACP can be combined with other treatments and has very few adverse effects. It takes 10-14 days for SARS-CoV2-infected patients to produce virus-neutralizing antibodies: within that time they can develop serious complications and die. Injecting PAC into patients with severe forms of COVID-19 shortens the period of risk while the patient produces the antibodies.

NCT ID: NCT04368182 Recruiting - Clinical trials for Hepatocellular Carcinoma

AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma

Start date: April 13, 2020
Phase: Phase 1
Study type: Interventional

A study that aimed to assess the safety and anti-tumor activity of C-TCR055 injection in unresectable HCC patients

NCT ID: NCT04377841 Recruiting - Rosacea Clinical Trials

Facial Demodicosis and Ocular Demodicosis

Start date: April 13, 2020
Phase:
Study type: Observational

To understand the association between facial demodicosis and ocular demodicosis, we plan to enroll patients with facial demodicosis, ocular demodicosis, or both, in order to analyze their clinical presentations, the density of Demodex infestation over facial skin and eyelashes, and possible risk factors of the two diagnoses.